Pietro Manuel Ferraro
Overview
Explore the profile of Pietro Manuel Ferraro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
2417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pollastri F, Fassio A, Ferraro P, Andreola S, Gambaro G, Spasiano A, et al.
Calcif Tissue Int
. 2025 Feb;
116(1):42.
PMID: 39982454
Kidney transplant recipients (KTRs) have an elevated fracture risk. While dual-energy X-ray absorptiometry (DXA) is commonly used to assess areal bone mineral density (aBMD), it does not capture all aspects...
2.
Lombardi G, Chesnaye N, Caskey F, Dekker F, Evans M, Heimburger O, et al.
Clin Kidney J
. 2024 Dec;
17(11):sfae254.
PMID: 39669396
Background: We aimed to explore the relationship between serum bicarbonate (SBC) and mortality in advanced chronic kidney disease (CKD) during three distinct treatment periods: during the pre-kidney replacement therapy (KRT)...
3.
Mandrile G, Cellini B, Ferraro P
Curr Opin Nephrol Hypertens
. 2024 Dec;
34(2):177-183.
PMID: 39641329
Purpose Of Review: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder of hepatic glyoxylate metabolism leading to nephrolithiasis and kidney failure. PH1 is caused by mutations on the...
4.
Mezza T, Wewer Albrechtsen N, Giuseppe G, Ferraro P, Soldovieri L, Ciccarelli G, et al.
Metabolism
. 2024 Dec;
163:156087.
PMID: 39626843
Aims: A number of studies have suggested that pancreatic α cells produce intact GLP-1, thereby constituting a gut-independent paracrine incretin system. However, the debate on whether human α cells contain...
5.
Barbieri G, Cazzoletti L, Melotti R, Hantikainen E, Lundin R, Barin L, et al.
J Nephrol
. 2024 Nov;
PMID: 39602026
Background: Kidney diseases are a public health burden but are poorly investigated in the general population. In light of inadequate survey tools, we developed a novel questionnaire for use in...
6.
Spasiano A, Treccani M, De Tomi E, Malerba G, Gambaro G, Ferraro P
Genes (Basel)
. 2024 Nov;
15(11).
PMID: 39596670
Background: Kidney stone disease (KSD) is characterized by an increasing prevalence worldwide, representing an important clinical issue and a financial burden for healthcare systems. A KSD-causing monogenic variant is traditionally...
7.
Ortiz A, Kramer A, Ariceta G, Rodriguez Arevalo O, Gjerstad A, Santiuste C, et al.
Nephrol Dial Transplant
. 2024 Nov;
PMID: 39508350
Background: Inherited kidney diseases (IKD) and congenital anomalies of the kidney and urinary tract (CAKUT) are causes of kidney failure requiring kidney replacement therapy (KRT) that major renal registries usually...
8.
Hsia J, Shivappa N, Bakhai A, Bover J, Butler J, Ferraro P, et al.
Clin Kidney J
. 2024 Oct;
17(10):sfae295.
PMID: 39464260
Background: Guideline-recommended hyperkalaemia management includes dietary potassium (K) restriction, bicarbonate correction, diuretics and K binders with dose reduction of renin-angiotensin-aldosterone system inhibitors as a last resort. The extent to which...
9.
Fassio A, Adami G, Andreola S, Ferraro P, Pisani P, Lombardi F, et al.
Diagnostics (Basel)
. 2024 Sep;
14(18).
PMID: 39335785
: A significant loss in bone density and strength occurs during the post-renal-transplant period with higher susceptibility to fracture. The study aims to compare the performance of the Radiofrequency Echographic...
10.
Socioeconomic Inequalities Worsen the Risk of Death in CKD: A Population-Based Cohort Study in Italy
Giaccari M, Marino C, Ferraro P, Cesaroni G, Davoli M, Agabiti N
Kidney360
. 2024 Sep;
5(12):1853-1861.
PMID: 39325555
No abstract available.